Miractil
Product Images NDC 69492-011

12 FDA label images from Polimeros Y Servicios S.a- · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Miractil (NDC 69492-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Polimeros Y Servicios S.a-, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Active Ingredients)

Image Description (Active Ingredients)
A Drug Facts panel listing active ingredients and their purposes. Ingredients include Cocoa butter 12.5%, Glycerin 12.5% (both protectants), Menthol 0.1% (analgesic, antipruritic, anesthetic), White petrolatum 15% (protectant), and Zinc oxide 12.5% (protectant).*
FDA Label Image

Image Description (Container Label)

Image Description (Container Label)
Drug Facts and directions panel for Miractil Hemorrhoidal Cream by Polimeros y Servicios S.A. Includes dosage instructions, inactive ingredients, drug facts with active ingredients and purposes, indications for use, warnings, allergy alert, and packaging information. The label highlights superior polyelectrolyte technology and soothing irritation features. Net weight is 1.06 oz (30g). Contact numbers and storage instructions are also provided.*
FDA Label Image

Image Description (Directions)

Image Description (Directions)
The image shows a partial Drug Facts panel for MIRACTIL, focusing on the Directions section. It provides application instructions for adults, emphasizing cleansing the affected area, drying, and applying the product externally up to six times daily or after bowel movements. It also advises consulting a physician for children under 12 years old.*
FDA Label Image

Image Description (Dosage And Administration)

Image Description (Dosage And Administration)
This image shows a continuation of the Drug Facts panel for MIRACTIL, providing directions for use. It advises adults to cleanse the affected area with mild soap and water, dry gently, and apply the product externally up to six times daily or after each bowel movement. It also recommends consulting a physician for children under 12 years of age.*
FDA Label Image

Image Description (Inactive Ingredinets)

Image Description (Inactive Ingredinets)
A continuation of the Drug Facts panel listing inactive ingredients for the product MIRACTIL. The inactive ingredients include carbomer, chitosan, demineralized purified water, methyl paraben, phosphate buffer, polycarbophile, propyl paraben, and white mineral oil gel.*
FDA Label Image

Image Description (Indications)

Image Description (Indications)
The image shows a Drug Facts panel detailing the indications for use, including temporary relief of local pain, itching, burning, and discomfort associated with hemorrhoids, protection of inflamed anorectal surfaces during bowel movements, and formation of a protective coating over inflamed tissues to prevent drying. It also notes that the product may provide a cooling sensation.*
FDA Label Image

Image Description (Keep Out Of Reavh Of Children)

Image Description (Keep Out Of Reavh Of Children)
A Drug Facts label section for MIRACTIL including warnings about consulting a doctor if conditions worsen or do not improve within 7 days, not exceeding recommended dosage, and prompt consultation in case of bleeding. It also contains an allergy alert advising discontinuation and medical consultation if allergic reactions or symptoms worsen. The label emphasizes keeping the product out of reach of children and indicates it is for external use only.*
FDA Label Image

Image Description (Other Information)

Image Description (Other Information)
A drug facts or text panel section providing storage instructions for MIRACTIL. It states that the product is best stored between 40°F and 90°F, offering information relevant to the handling and storage conditions of the medication.*
FDA Label Image

Image Description (Package Content Of Labeling)

Image Description (Package Content Of Labeling)
Miractil Hemorrhoidal Cream packaging label showing the brand name Miractil with active ingredients including cocoa butter, glycerin, menthol, white petrolatum, and zinc oxide. The label highlights superior polyelectrolyte technology, soothing irritation benefits, and a net weight of 1.06 oz (30g). Manufacturer information and drug facts including warnings, directions, inactive ingredients, and indications are also visible, with Miractil labeled as a hemorrhoidal cream by Polimeros y Servicios S.A.*
FDA Label Image

Image Description (Purpose)

Image Description (Purpose)
Drug Facts panel showing active ingredients and their purposes for MIRACTIL. Ingredients listed include Cocoa butter 12.5% (Protectant), Glycerin 12.5% (Protectant), Menthol 0.1% (Analgesic, antipruritic, anesthetic), White petrolatum 15% (Protectant), and Zinc oxide 12.5% (Protectant).*
FDA Label Image

Image Description (Questions Or Comments)

Image Description (Questions Or Comments)
Text panel showing customer service contact information for MIRACTIL, providing two phone numbers and hours of availability from 9 am to 5 pm CST on weekdays for questions or comments.*
FDA Label Image

Image Description (Warnings)

Image Description (Warnings)
A continuation of the Drug Facts panel for MIRACTIL by POLIMEROS Y SERVICIOS S.A. This section includes warnings about consulting a doctor if condition worsens or fails to improve within 7 days, not exceeding recommended dosage, and prompts for external use only. It also contains an allergy alert advising discontinuation and medical consultation if allergic reactions occur, along with a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.